MyDx Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
3.10
753.50
143.70
38.20
119.00
102.70
Total Accounts Receivable
-
-
10.70
27.90
-
-
Inventories
-
-
452.00
155.20
180.50
114
Other Current Assets
-
293.80
52.00
80.00
0.80
-
Total Current Assets
3.10
1,047.30
658.30
301.30
300.40
216.70
Net Property, Plant & Equipment
-
103.60
233.10
138.90
66.80
200.60
Other Assets
-
6.40
104.40
49.80
32.60
19
Total Assets
3.10
1,157.40
995.80
490.00
399.80
436.30
ST Debt & Current Portion LT Debt
0.20
2,001.80
50.60
357.10
298.50
Accounts Payable
-
537.10
619.50
1,082.40
1,293.40
Other Current Liabilities
-
592.10
295.10
2,209.00
3,116.60
Total Current Liabilities
0.20
3,130.90
965.20
3,648.50
4,708.50
Long-Term Debt
-
-
375.30
200.00
-
Other Liabilities
-
-
2.70
-
9.00
Total Liabilities
0.20
3,130.90
1,343.20
3,848.50
4,717.50
Common Equity (Total)
2.90
1,973.60
347.40
9,058.50
9,955.00
Total Shareholders' Equity
2.90
1,973.60
347.40
3,358.50
4,317.70
Total Equity
2.90
1,973.60
347.40
3,358.50
4,317.70
Liabilities & Shareholders' Equity
3.10
1,157.40
995.80
490.00
399.80
Preferred Stock (Carrying Value)
-
-
-
5,700.00
5,637.30

About MyDx

View Profile
Address
6335 Ferris Square
San Diego California 92121
United States
Employees -
Website http://www.mydxlife.com
Updated 07/08/2019
MyDx, Inc. is a science and technology company, which engages in the development of MyDx, a patented multiuse hand-held chemical analyzer designed to help consumers and professional test for pesticides in food, chemicals in water, toxins in the air, and safety and potency of cannabis samples. It operates through the following segments: Consumer Products, Data Analytics, Biopharmaceutical, and Software as a Service (SaaS). The Consumer Products segment offers smart Devices and consumables.